iOS app Android app

Costly Mistakes

Pfizer Loses $2.8 Bil In Costly Insulin Flop

Wall Street Journal | AVERY JOHNSON | Posted 05.25.2011 | Business

Pfizer Inc.'s decision to shelve a novel insulin inhaler and take a $2.8 billion pretax hit on the product -- one of the drug industry's costliest fai...